Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beyond AirFRA:48L 25 Buyback Yield % is -224.61 as of Jul. 14, 2026. GuruFocus rates FRA:48L with a GF Score™ of 25/100 and a GF Value™ of €1,073.24. The stock has 7 warning signs investors should review. Among 346 Medical Devices & Instruments companies, Beyond Air ranks worse than 97.69% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Beyond Air's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:48L vs VVOS, TNON, BMRA: Buyback Yield % Comparison
For the Medical Devices subindustry, Beyond Air's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beyond Air Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Beyond Air's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (FRA:48L) has a Buyback Yield % of -224.61 as of Jul. 14, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beyond Air and its competitors. According to the industry distribution chart, Beyond Air ranks #338 out of 346 companies in the Medical Devices & Instruments industry, placing it in the top 97.7%.
Is Beyond Air's Buyback Yield % too high?
Beyond Air's current Buyback Yield % is -224.61. Based on the distribution chart, Beyond Air ranks #338 out of 346 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beyond Air has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Beyond Air's Buyback Yield % compare to VVOS and TNON?
According to the Medical Devices & Instruments industry distribution chart, Beyond Air ranks #338 out of 346 companies for Buyback Yield %. This places Beyond Air in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beyond Air and its competitors. Beyond Air's current Buyback Yield % is -224.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beyond Air stock overvalued right now?
Beyond Air (FRA:48L) has a current Buyback Yield % of -224.61. The stock's GF Value™ is €1,073.24, compared to a current price of €65.60 — trading 93.9% below its estimated fair value. The current Buyback Yield % is -224.61. Beyond Air's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Beyond Air (FRA:48L), the current Buyback Yield % is -224.61 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beyond Air (FRA:48L) Overvalued in 2026?
Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued.
The current stock price of €65.60 is trading 93.9% below its estimated GF Value™ of €1,073.24.
Key valuation signals for FRA:48L:
Buyback Yield %: -224.61
GF Value™: €1,073.24 vs. price of €65.60 (93.9% below fair value)
No single metric tells the full story. See the FRA:48L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
25GF Score
Get the complete analysis for FRA:48L
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:48L has been successfully added to your 
